Skip to main content
Premium Trial:

Request an Annual Quote

Sanofi Taps Foundation Medicine for Biomarker, Companion Dx Discovery

NEW YORK (GenomeWeb News) – Foundation Medicine said today that it will use its genome sequencing and analysis services to identify genetic biomarkers and potential companion diagnostics for oncology drug candidates for Sanofi.

Foundation Medicine uses next-generation sequencing to analyze clinical specimens for molecular alterations in around 200 cancer-related genes. Its cancer genomic test is designed to provide clinical-grade analysis of tumor tissues, and test results are reported through a secure website that links pertinent genomic data to a knowledge base of relevant, publicly available data.

"Targeted cancer therapeutics routinely demonstrate improved clinical safety and efficacy when matched with the patients most likely to benefit, and we believe this alliance with Sanofi will help catalyze the development of their targeted candidates," Foundation Medicine President and CEO Michael Pellini said in a statement.

Financial terms of the agreement were not released.

The agreement with Sanofi marks the company's fifth collaboration with a pharmaceutical firm. It has signed similar deals with Johnson & Johnson Pharmaceutical Research and Development, Novartis, Celgene, and an undisclosed firm.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.